Clinical Trials Logo

Clinical Trial Summary

Pseudoexfoliation syndrome (PEX) is characterized by the deposition of a distinctive fibrillar material in the anterior segment of the eye and was first described in 1917 by Lindberg. It is frequently associated with open angle glaucoma, known as pseudoexfoliation glaucoma, which is one of the most common identifiable forms of secondary open angle glaucoma worldwide. Despite extensive research, the exactchemical nature of the fibrillar material is unknown. It is believed to be secreted multifocally in the iris pigment epithelium, the ciliary epithelium, and the peripheral anterior lens epithelium.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03741153
Study type Observational
Source Assiut University
Contact
Status Not yet recruiting
Phase
Start date January 2019
Completion date March 14, 2021

See also
  Status Clinical Trial Phase
Recruiting NCT05158699 - Effectiveness of Periocular Drug Injection in CATaract Surgery Phase 3
Completed NCT04072939 - Retinal Detachment After Lens Surgery in the Nearsighted
Terminated NCT04969406 - A Prospective Trial of the Intelon BOSS(TM) System N/A
Active, not recruiting NCT01763411 - Visual Performance of Pseudophakic Patient With Different Intraocular Lenses N/A
Completed NCT00576485 - Spherical Aberration and Contrast Sensitivity in IOLs Phase 4
Recruiting NCT05290896 - Correlations Between Lens Star and Phacoemulsification. N/A
Completed NCT03655743 - PRO Measure for Refractive Surgery IRAS Project Number 246072
Completed NCT05368870 - Accuracy of Intra Ocular Lens CARLEVALE Calculation